Narrow Your Results
A Phase 2A Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of 50 mg and 100 mg of SUVN-502 in Subjects with Moderate Alzheimer’s Disease Currently Treated with Donepezil Hydrochloride and Memantine Hydrochloride
The purpose of this study is to see if SUVN-502 has an effect in improving symptoms of Alzheimer’s disease, to see if it is safe, to see how well it is tolerated, and to measure the levels of SUVN-502 in the blood. You are being invited to participate because you have moderate Alzheimer’s disease and are currently taking the marketed medications called...
Carotid Stenosis Trial (PRO00002828)
The purpose of this research study is to find out if medical management alone results in different rates of death or stroke than medical management and a surgical procedure.
Niemann-Pick Type C1 Disease (PRO00003302)
The purpose of this research study is to determine if a drug called 2-hydroxypropyl- β-cyclodextrin (VTS-270) will keep your child with NPC1 from getting sicker.